Literature DB >> 31893005

Surgical closure of large splenorenal shunt may accelerate recovery from hepato-pulmonary syndrome in liver transplant patients.

Yan-Jun Shi1,2, Patrick Mckiernan2, Kyle Soltys2, George Mazariegos2, Wei-Lin Wang1.   

Abstract

Entities:  

Year:  2020        PMID: 31893005      PMCID: PMC6885588          DOI: 10.5847/wjem.j.1920-8642.2020.01.009

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


× No keyword cloud information.
  21 in total

1.  Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease.

Authors:  W E Hopkins; A D Waggoner; B Barzilai
Journal:  Am J Cardiol       Date:  1992-08-15       Impact factor: 2.778

2.  Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience.

Authors:  J K Stoller; P A Lange; M K Westveer; W D Carey; D Vogt; J M Henderson
Journal:  West J Med       Date:  1995-08

3.  Is severe arterial hypoxaemia due to hepatic disease an indication for liver transplantation? A new therapeutic approach.

Authors:  R Rodriguez-Roisin; M J Krowka
Journal:  Eur Respir J       Date:  1994-05       Impact factor: 16.671

4.  Hepatopulmonary syndrome: favorable outcomes in the MELD exception era.

Authors:  Vivek N Iyer; Karen L Swanson; Rodrigo Cartin-Ceba; Ross A Dierkhising; Charles B Rosen; Julie K Heimbach; Russell H Wiesner; Michael J Krowka
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

5.  Hemodynamic consequences of spontaneous splenorenal shunts in deceased donor liver transplantation.

Authors:  Federico Castillo-Suescun; Gabriel C Oniscu; Ernest Hidalgo
Journal:  Liver Transpl       Date:  2011-08       Impact factor: 5.799

6.  Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome.

Authors:  Federico P Gómez; Graciela Martínez-Pallí; Joan A Barberà; Josep Roca; Miquel Navasa; Robert Rodríguez-Roisin
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

7.  Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.

Authors:  Junlan Zhang; Bao Luo; Liping Tang; Yongming Wang; Cecil R Stockard; Inga Kadish; Thomas Van Groen; William E Grizzle; Selvarangan Ponnazhagan; Michael B Fallon
Journal:  Gastroenterology       Date:  2008-12-03       Impact factor: 22.682

8.  Vascular steal of the portal vein after orthotopic liver transplant: intraoperative sonographic diagnosis.

Authors:  Mindy M Horrow; Matthew A Phares; Narayan Viswanadhan; Radi Zaki; Victor Araya; Jorge Ortiz
Journal:  J Ultrasound Med       Date:  2010-01       Impact factor: 2.153

9.  Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice.

Authors:  Sarah Raevens; Anja Geerts; Annelies Paridaens; Sander Lefere; Xavier Verhelst; Anne Hoorens; Jo Van Dorpe; Tania Maes; Ken R Bracke; Christophe Casteleyn; Bart Jonckx; Thomas Horvatits; Valentin Fuhrmann; Hans Van Vlierberghe; Christophe Van Steenkiste; Lindsey Devisscher; Isabelle Colle
Journal:  Hepatology       Date:  2018-05-11       Impact factor: 17.425

10.  Splenic Artery Embolization for Treatment of Refractory Ascites After Liver Transplantation.

Authors:  Alireza Meighani; Syed-Mohammed R Jafri; Mohammad Raoufi; Reena Salgia
Journal:  ACG Case Rep J       Date:  2016-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.